Ubs Group Ag Theratechnologies Inc. Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.78 - $1.01 $3,875 - $5,017	-4,968 Reduced 7.24%	63,651 $53,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.12 $2,514 - $3,912	3,493 Added 5.36%	68,619 $55,000
Q4 2022 Feb 08, 2023	SELL	$0.83 - $8.04 $1,189 - $11,521	-1,433 Reduced 2.15%	65,126 $57,000
Q3 2022 Nov 10, 2022	BUY	$1.98 - $2.42 $10,492 - $12,823	5,299 Added 8.65%	66,559 $158,000
Q2 2022 Aug 10, 2022	SELL	$2.21 - $2.7 $15,912 - $19,440	-7,200 Reduced 10.52%	61,260 $139,000
Q1 2022 May 16, 2022	SELL	$2.37 - $3.24 $30,819 - $42,132	-13,004 Reduced 15.96%	68,460 $168,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $3.76 $10,620 - $13,675	-3,637 Reduced 4.27%	81,464 $247,000
Q3 2021 Nov 15, 2021	SELL	$3.28 - $4.07 $6,701 - $8,315	-2,043 Reduced 2.34%	85,101 $320,000
Q2 2021 Aug 13, 2021	BUY	$3.43 - $3.96 $41,307 - $47,690	12,043 Added 16.04%	87,144 $338,000
Q1 2021 May 12, 2021	SELL	$2.2 - $3.94 $129,496 - $231,916	-58,862 Reduced 43.94%	75,101 $290,000
Q4 2020 Feb 11, 2021	BUY	$1.91 - $2.5 $154,801 - $202,620	81,048 Added 153.17%	133,963 $335,000
Q3 2020 Nov 12, 2020	SELL	$1.96 - $2.92 $1,321 - $1,968	-674 Reduced 1.26%	52,915 $117,000
Q2 2020 Jul 31, 2020	SELL	$1.58 - $2.86 $17,319 - $31,351	-10,962 Reduced 16.98%	53,589 $107,000
Q1 2020 May 01, 2020	BUY	$1.43 - $3.23 $35,321 - $79,781	24,700 Added 61.98%	64,551 $103,000
Q4 2019 Feb 14, 2020	BUY	$2.74 - $4.2 $109,191 - $167,374	39,851 New	39,851 $131,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.